ReGelTec Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

ReGelTec General Information

Description

Developer of injectable hydrogel technology intended to address chronic lower back pain associated with degenerative disc disease. The company uses a proprietary gel that transitions from liquid to solid within the intervertebral disc to mimic natural disc biomechanics and maintain spinal motion, enabling healthcare providers and patients to access a minimally invasive treatment option aimed at preserving mobility and reducing pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 323 West Camden Street
  • Suite 600
  • Baltimore, MD 21201
  • United States
+1 (443)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Surgical Devices
Corporate Office
  • 323 West Camden Street
  • Suite 600
  • Baltimore, MD 21201
  • United States
+1 (443)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ReGelTec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Clinical Trials - General
4. Accelerator/Incubator 06-Jun-2025 Completed Clinical Trials - General
3. Angel (individual) 01-Oct-2023 Completed Clinical Trials - General
2. Early Stage VC (Series A) 15-Oct-2020 $4M $6M Completed Product Development
1. Seed Round 07-Sep-2018 $2M $2M Completed Startup
To view ReGelTec’s complete valuation and funding history, request access »

ReGelTec Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view ReGelTec’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ReGelTec Patents

ReGelTec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10507264-B1 Cross-linked hydrogels and method of making the same Active 07-Jan-2019
JP-2022522944-A Hydrogel and its manufacturing method Active 07-Jan-2019
JP-7663949-B2 Hydrogel and method for producing same Active 07-Jan-2019
AU-2020205635-A1 Hydrogels and method of making the same Active 07-Jan-2019
AU-2020205635-B2 Hydrogels and method of making the same Active 07-Jan-2019 A61L27/52
To view ReGelTec’s complete patent history, request access »

ReGelTec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ReGelTec Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
Riptide Ventures Angel Group Minority
Keiretsu Forum Angel Group Minority
PTX Capital Venture Capital Minority
Tech Council Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

ReGelTec FAQs

  • When was ReGelTec founded?

    ReGelTec was founded in 2018.

  • Where is ReGelTec headquartered?

    ReGelTec is headquartered in Baltimore, MD.

  • What is the size of ReGelTec?

    ReGelTec has 10 total employees.

  • What industry is ReGelTec in?

    ReGelTec’s primary industry is Therapeutic Devices.

  • Is ReGelTec a private or public company?

    ReGelTec is a Private company.

  • What is ReGelTec’s current revenue?

    The current revenue for ReGelTec is .

  • How much funding has ReGelTec raised over time?

    ReGelTec has raised $6M.

  • Who are ReGelTec’s investors?

    MedTech Innovator, Riptide Ventures, Keiretsu Forum, PTX Capital, and Tech Council Ventures are 5 of 6 investors who have invested in ReGelTec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process